NATIONAL CENTER FOR TRANSLATIONAL MEDICINE · NATIONAL MEDICAL CENTER FOR HEMATOLOGY
Ruijin Hospital, SJTU School of Medicine
Established in 1907 as Sainte Marie Hospital, Ruijin Hospital of Shanghai Jiao Tong University School of Medicine is one of China’s most celebrated centennial public tertiary academic medical complexes. Formally designated as the National Medical Center for Hematologic Diseases and home to the National Center for Translational Medicine, Ruijin represents global leadership in leukemia targeted differentiation, CAR-T cellular immunotherapy, and robotic cancer surgery.
Built upon the pioneering legacy of Lasker Award laureate Academician Wang Zhenyi and Academician Chen Zhu, Ruijin’s Shanghai Institute of Hematology manages the highest volume of commercial and clinical-trial CAR-T cell infusions in Asia, achieving remarkable complete remission rates in refractory lymphomas, multiple myeloma, and acute lymphoblastic leukemia.
FOUR CLINICAL EXCELLENCE PILLARS
Core Hematology & Surgical Capabilities
Ruijin Hospital integrates world-renowned hematologic oncology research with cutting-edge robotic minimally invasive surgery across complex abdominal and thoracic malignancies.
CAR-T & Cellular Therapy
Comprehensive commercial and investigational CAR-T programs for relapsed/refractory lymphoma, myeloma, and leukemia.
Hematologic Malignancies
Pioneering targeted differentiation protocols (ATRA + Arsenic) and high-volume allogeneic stem cell transplantation.
Robotic Pancreatic Surgery
Asia’s leading robotic pancreaticoduodenectomy (Whipple) center with superior vascular reconstruction and lymphadenectomy.
Translational Medicine Hub
National Center for Translational Medicine offering immediate access to molecular genomic testing and novel clinical trials.
WORLD-RENOWNED HEMATOLOGY & SURGICAL CHIEFS
Academic Faculty & Department Leadership
Steered by members of the Chinese Academy of Sciences and Chinese Academy of Engineering.
Academician Wang Zhenyi Faculty
Lasker Award winner and pioneer of all-trans retinoic acid (ATRA) for acute promyelocytic leukemia, transforming a fatal malignancy into a 95%+ curable condition.
Prof. Mi Jianqing, MD, PhD
National leader in clinical CAR-T cell immunotherapy and autologous/allogeneic stem cell transplantation for advanced lymphoma and multiple myeloma.
CASE INTAKE & SPECIALIST TRIAGE
Initiate Your Case Review with Ruijin Hospital
Submit your contact details, confirmed diagnosis, and main question below. You do not need to upload any medical files at this stage. Our clinical coordinator will contact you directly within 24–48 hours to discuss potential Ruijin Hospital clinical pathways in China and assist you in gathering the specific medical records needed for expert hospital review.
PATIENT INQUIRIES
Frequently Asked Questions About Ruijin Hospital
Key clinical, logistical, and technical facts regarding international admissions, surgical evaluations, advanced technology access, and personalized care coordination at Ruijin Hospital.
Patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, mantle cell lymphoma, B-cell acute lymphoblastic leukemia (B-ALL), or multiple myeloma who have failed at least two prior lines of therapy.
From T-cell apheresis to final cell product delivery typically requires 2 to 3 weeks. Patients usually remain hospitalized for approximately 2 to 3 weeks post-infusion for close monitoring and recovery.
Ruijin’s robotic surgery center performs the highest volume of robotic Whipple procedures in Asia, offering magnified 3D visualization, superior tremor filtration, and reduced blood loss, enabling faster return to oncologic chemotherapy.
Yes. Ruijin’s National Center for Translational Medicine regularly enrolls eligible overseas patients in cutting-edge bispecific antibody and next-generation CAR-T cellular trials under formal ethical clearance.
MODERN CLINICAL INFRASTRUCTURE
Strategic Multi-Campus Setup & International Transit
Modern clinical hubs designed for seamless aeromedical transport, multidisciplinary conferences, and dedicated international inpatient care.
Ruijin Historic Downtown Campus
197 Ruijin 2nd Road, Huangpu District, Shanghai
The central academic hospital housing the National Center for Translational Medicine, Institute of Hematology, and VIP towers.
Ruijin Northern Campus (Jiading)
999 Xiwang Road, Jiading District, Shanghai
Modern medical center featuring specialized oncology wards, comprehensive imaging infrastructure, and radiation pavilions.